Genomic alterations in prostate cancer therapeutic targets were found to be similar between African American and European American men, suggesting that existing precision medicine approaches could equally benefit both groups if applied equitably, according to a recent study.
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
A drug commonly used to reduce serum urate levels proved ineffective in slowing disease progression in patients with diabetic kidney disease, according to a recent study.
A Northwestern Medicine study found that inducing inflammation in lung epithelial cells contributes to the development of chronic obstructive pulmonary disease.
Northwestern Medicine scientists have developed a novel cell lineage tracing method that can better determine the origin of mammalian neuron populations from progenitor cells.
As health inequities affect vulnerable populations, healthcare organizations must shift to a health equity centered, population health approach, according to a recent position paper from the National Academy of Medicine.
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.